Development of anti-TNF therapy for rheumatoid arthritis.
The aetiology of systemic, autoimmune, chronic inflammatory diseases--such as rheumatoid arthritis--is not known, and their pathogenesis is complex and multifactorial. However, progress in the characterization of intercellular mediators--proteins that are now known as cytokines--has led to the reali...
Autor principal: | Feldmann, M |
---|---|
Formato: | Journal article |
Lenguaje: | English |
Publicado: |
2002
|
Ejemplares similares
-
ANTI TNF THERAPY IN RHEUMATOID ARTHRITIS
por: Feldmann, M, et al.
Publicado: (2011) -
TNF-alpha in rheumatoid arthritis and prospects of anti-TNF therapy.
por: Maini, R, et al.
Publicado: (1993) -
Anti-TNF biologic agents: still the therapy of choice for rheumatoid arthritis.
por: Taylor, P, et al.
Publicado: (2009) -
Anti-TNF alpha therapy of rheumatoid arthritis: what have we learned?
por: Feldmann, M, et al.
Publicado: (2001) -
Insights into the pathogenesis of rheumatoid arthritis from application of anti-TNF therapy.
por: Maini, R, et al.
Publicado: (2000)